Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Tablets: SOP for Packaging of Chewable and Dispersible Tablets – V 2.0

Posted on By

Tablets: SOP for Packaging of Chewable and Dispersible Tablets – V 2.0

Standard Operating Procedure for Packaging of Chewable and Dispersible Tablets

Department Tablet
SOP No. SOP/TAB/249/2025
Supersedes SOP/TAB/249/2022
Page No. Page 1 of 6
Issue Date 01/07/2026
Effective Date 06/07/2026
Review Date 01/07/2027

1. Purpose

The purpose of this SOP is to define the procedure for packaging chewable and dispersible tablets to ensure that they are correctly and securely packaged, preserving their quality, stability, and safety until they reach the consumer. The SOP aims to ensure compliance with GMP and regulatory standards.

2. Scope

This SOP applies to the packaging of all chewable and dispersible tablets manufactured at the site. It includes the procedures for packing tablets into blister packs, bottles, or other suitable packaging, ensuring compliance with the required quality standards and regulatory guidelines.

3. Responsibilities

  • Packaging Operators: Responsible for the correct operation of packaging machines, application of labels, and ensuring the correct packaging of chewable and dispersible tablets.
  • Quality Control (QC): Responsible for overseeing the packaging process, verifying that all packaging operations are performed correctly, and ensuring compliance with quality standards.
  • Production Manager: Ensures that the packaging process is conducted according to the SOP and takes corrective action if any deviations or issues arise during the packaging process.

4. Accountability

The Production Manager is accountable for ensuring that the packaging of chewable and dispersible tablets follows the SOP. The QC Manager is responsible for confirming the quality of the final packaged products.

5. Procedure

5.1 Preparation for Packaging

  1. Ensure that the chewable and dispersible tablets are ready for packaging and have undergone all necessary quality checks, including hardness, disintegration, and weight uniformity testing (Annexure-1).
  2. Verify that the correct packaging materials are available for the batch, including blister packs, bottles, or other containers, and that they comply with the approved specifications (Annexure-2).
  3. Ensure that the labeling and secondary packaging materials (e.g., cartons, leaflets) are available and match the approved design (Annexure-3).
See also  Tablets: SOP for pH Adjustment Analysis in Enteric-Coating Materials - V 2.0

5.2 Packaging Process

  1. Start the packaging process by setting up the packaging machine according to the batch specifications (Annexure-4).
  2. For blister packaging, ensure that the blister cavities are properly aligned and filled with the correct number of tablets (Annexure-5).
  3. For bottle packaging, ensure that the correct quantity of tablets is filled into each bottle (Annexure-6).
  4. Ensure that the labeling machine applies the correct labels on each package, including the product name, batch number, expiry date, and any other regulatory information (Annexure-7).
  5. Verify that all tamper-evident seals and closure systems are applied correctly to maintain product integrity (Annexure-8).
  6. If any issues such as misalignment, broken seals, or incorrect labeling are detected, stop the process and rectify the issue before continuing (Annexure-9).

5.3 Quality Checks During Packaging

  1. QC personnel must inspect a sample of each batch during packaging to ensure that the labeling, sealing, and packaging materials are compliant with specifications (Annexure-10).
  2. Check that the packaging is properly sealed and there is no visible damage (Annexure-11).
  3. If any non-compliance is found, the batch should be quarantined until the issue is resolved (Annexure-12).

5.4 Post-Packaging Inspections

  1. Once packaging is completed, inspect the finished product for any packaging defects, such as damaged blister packs, incorrect labels, or improperly sealed bottles (Annexure-13).
  2. Conduct a final weight check and verify that all regulatory information is included (Annexure-14).
  3. Prepare the packaged tablets for storage or distribution, following the appropriate procedures for finished goods handling (Annexure-15).

5.5 Documentation and Record-Keeping

  1. Maintain a detailed log of the packaging process, including batch number, packaging date, and the quantity of tablets packed (Annexure-16).
  2. Ensure that all packaging records are retained for a minimum of two years or as required by regulatory authorities (Annexure-17).

6. Abbreviations

  • SOP: Standard Operating Procedure
  • GMP: Good Manufacturing Practice
  • QC: Quality Control
  • FDA: Food and Drug Administration
  • EMA: European Medicines Agency
See also  Tablets: SOP for Fluidized Bed Granulation Methodology - V 2.0

7. Documents

  1. Batch Record Log (Annexure-1)
  2. Packaging Material Specifications (Annexure-2)
  3. Labeling Specifications (Annexure-3)
  4. Packaging Machine Setup Log (Annexure-4)
  5. Blister Pack Inspection Log (Annexure-5)
  6. Bottle Packaging Inspection Log (Annexure-6)
  7. Label Application Log (Annexure-7)
  8. Sealing and Tamper-Evident Seal Check Log (Annexure-8)
  9. Packaging Defect Report (Annexure-9)
  10. Post-Packaging Inspection Log (Annexure-10)
  11. Finished Goods Inspection Log (Annexure-11)
  12. Final Weight Check Log (Annexure-12)
  13. Finished Goods Storage Log (Annexure-13)
  14. Packaging Process Log (Annexure-14)
  15. Finished Goods Documentation Log (Annexure-15)
  16. Packaging Records Retention Log (Annexure-16)
  17. Packaging Compliance Records (Annexure-17)

8. References

  • 21 CFR Part 211 – Current Good Manufacturing Practice for Finished Pharmaceuticals (FDA)
  • USP <1079> – Good Storage and Distribution Practices
  • ISO 9001 – Quality Management Systems

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Batch Record Log

Batch Number Batch Size Packaging Date Operator
Batch 12345 1000 tablets 01/07/2026 John Doe

Annexure-2: Packaging Material Specifications

Material Type Specification Quantity
Blister Pack 3×5, PVC 1000 units

Annexure-3: Labeling Specifications

Label Type Font Size Text Color Material
Primary Label 12 pt Black Gloss Paper
Secondary Label 10 pt Blue Matte Paper

Annexure-4: Packaging Machine Setup Log

Machine ID Setup Date Operator Setup Completed
Machine 01 01/07/2026 John Doe Yes
Machine 02 01/07/2026 Jane Smith Yes

Annexure-5: Blister Pack Inspection Log

Batch Number Inspection Date Inspector Comments
Batch 12345 01/07/2026 Jane Smith Compliant – No issues found
Batch 12346 02/07/2026 John Doe Compliant – No issues found

Annexure-6: Bottle Packaging Inspection Log

Batch Number Inspection Date Inspector Comments
Batch 12345 01/07/2026 Jane Smith Compliant – No issues found
Batch 12346 02/07/2026 John Doe Compliant – No issues found

Annexure-7: Label Application Log

Batch Number Label Application Date Operator Status
Batch 12345 01/07/2026 John Doe Completed
Batch 12346 02/07/2026 Jane Smith Completed

Annexure-8: Sealing and Tamper-Evident Seal Check Log

Batch Number Seal Inspection Date Inspector Seal Status
Batch 12345 01/07/2026 John Doe Pass
Batch 12346 02/07/2026 Jane Smith Pass

Annexure-9: Packaging Defect Report

Batch Number Defect Description Corrective Action Taken Reported By
Batch 12345 Incorrect label applied Reapplied the correct label John Doe
Batch 12346 Damaged packaging Repackaged and checked Jane Smith

Annexure-10: Post-Packaging Inspection Log

Batch Number Inspection Date Inspector Status
Batch 12345 01/07/2026 John Doe Pass
Batch 12346 02/07/2026 Jane Smith Pass

Annexure-11: Finished Goods Inspection Log

Batch Number Inspection Date Inspector Status
Batch 12345 01/07/2026 John Doe Pass
Batch 12346 02/07/2026 Jane Smith Pass

Annexure-12: Final Weight Check Log

Batch Number Check Date Weight Range Operator
Batch 12345 01/07/2026 Within specification John Doe

Annexure-13: Finished Goods Storage Log

Batch Number Storage Date Storage Location Storage Condition
Batch 12345 01/07/2026 Storage Area A Room Temperature, Dry
Batch 12346 02/07/2026 Storage Area B Refrigerated

Annexure-14: Packaging Process Log

Batch Number Process Start Date Operator Status
Batch 12345 01/07/2026 John Doe Completed
Batch 12346 02/07/2026 Jane Smith Completed

Annexure-15: Finished Goods Documentation Log

Document Type Document Reference Number Document Date
Packaging Record PR-12345 01/07/2026

Annexure-16: Packaging Records Retention Log

Material Type Retention Period Stored By Storage Location
Blister Packs 5 years John Doe Storage Area A

Annexure-17: Packaging Compliance Records

Batch Number Compliance Date Compliance Status Verified By
Batch 12345 01/07/2026 Compliant Jane Smith

18. Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/01/2024 1.0 Initial SOP creation New procedure QA Head
01/07/2026 2.0 Updated packaging procedure with new batch documentation logs and compliance records Process optimization and updated regulatory requirements QA Head
See also  Tablets: SOP for Compression Weight Control During Tablet Manufacturing - V 2.0
Tablet Manufacturing V2.0 Tags:GMP tablet manufacturing SOP, SOP for tablet production, SOP for tablet quality control, SOP tablet inspection process, SOP tablet packing and sealing, Tablet batch record review, Tablet blending SOP, Tablet cleaning and maintenance, Tablet coating procedure, Tablet compression SOP, Tablet disintegration test procedure, Tablet dissolution procedure, Tablet formulation SOP, Tablet friability testing SOP, Tablet labeling and packaging SOP, Tablet manufacturing equipment SOP, Tablet manufacturing SOP, Tablet manufacturing SOPs, Tablet packaging SOP, Tablet production procedure, Tablet quality assurance SOP, Tablet quality control SOP, Tablet sampling and in-process testing SOP, Tablet stability testing SOP, Tablet storage and handling procedure, Tablet uniformity testing procedure, Tablet weight variation SOP

Post navigation

Previous Post: BA-BE Studies: SOP for Dispensing of Investigational Medicinal Product (IMP) – V 2.0
Next Post: Creams: SOP for Calibrating and Validating Mixing Blades in Cream Manufacturing – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version